Delivery Order SPE2DB20D3505-SPE2DB22FT9X6
Award Date 7/1/22
Potential Completion Date 7/5/22
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,118.87 firm-fixed-price contract is for the supply of Victoza 3-Pak 18 mg/3 ml pens, with a period of performance through November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $20,451.94 and is for the delivery of Victoza 3-Pak 18 mg/3 ml pens. The contract is a Firm Fixed Price Delivery Order with a completion date of May 8, 2024. This contract award is not designated as a set-aside and appears to be competitively awarded. AmerisourceBergen also holds a...
- This federal contract award, valued at $5,398.86, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Victoza 3-Pak 18 MG/3 ML Pens to the government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,169.61 Firm Fixed Price Delivery Order is for the supply of Victoza 3-Pak 18 mg/3 ml Pen 3 ml pharmaceutical products. The award does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $2,047.84 firm fixed-price delivery order covers the supply of Victoza 3-Pak 18 mg/3 ml Pens with a completion date of July 25, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 firm fixed-price delivery order is for the supply of Victoza 3-Pak 18 mg/3 ml pen 3 ml, a medication used to manage diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,104.72 firm-fixed-price delivery order is for the supply of Victoza 3-pak 18 mg/3 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $2,154.27, is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,182.36 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 2-pak 18 mg/3 mL pens. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,731.39 fixed-price delivery order is for VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, with a completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT9X6Delivery Order
This is a federal contract award (SPE2DB20D3505|SPE2DB22FT9X6) from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,966.32 fixed-price delivery order is for the supply of Victoza 3-pak 18 mg/3 ml pens. This award is not designated as a set-aside contract. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, both of which cover a broad range of pharmaceutical and medical supply products to support federal healthcare programs.
Generated 2/27/25, 10:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/1/22 |